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A B S T R A C T
Current assessment of whether a forensic evidence item should be submitted for STR proﬁling is largely
based on the personal experience of the Crime Scene Investigator (CSI) and the submissions policy of the
law enforcement authority involved. While there are chemical tests that can infer the presence of DNA
through the detection of biological stains, the process remains mostly subjective and leads to many samples
being submitted that give no proﬁle or not being submitted although DNA is present. The ParaDNA1
Screening System was developed to address this issue. It consists of a sampling device, pre-loaded reaction
plates and detection instrument. The test uses direct PCR with ﬂuorescent HyBeaconTM detection of PCR
amplicons to identify the presence and relative amount of DNA on an evidence item and also provides a
gender identiﬁcation result in approximately 75 minutes. This simple-to-use design allows objective data
to be acquired by both DNA analyst and non-specialist personnel, to enable a more informed submission
decision to be made. The developmental validation study described here tested the sensitivity,
reproducibility, accuracy, inhibitor tolerance, and performance of the ParaDNA Screening System on a
range of mock evidence items. The data collected demonstrates that the ParaDNA Screening System
identiﬁes the presence of DNA on a variety of evidence items including blood, saliva and touch DNA items.
 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / fs ig1. Introduction
The creation of new DNA proﬁling technologies and their
application to forensic science is key to the ﬁeld’s development.
Improvements to the speed, sensitivity and power of discrimina-
tion are all common areas of research [1–3]. Recently there have
been moves towards the development of technologies focussing on
automation and portability which, together with cost reduction,
will usher in the next generation of forensic platforms [4].
Rapid DNA proﬁling is one such area of research and
development and has been growing in response to a desire from
enforcement authorities for both in-house control over the forensic
DNA process and rapid access to forensic genetic intelligence [5].* Corresponding author. Tel.: +44 844 2641 999/1235 1536.
E-mail addresses: paradna@lgcforensics.com, nick.dawnay@lgcforensics.com
(N. Dawnay).
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1872-4973/ 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access 
sa/3.0/).Such technologies either mirror the laboratory process (DNA
extraction, Polymerase Chain Reaction (PCR) and size separation)
by miniaturisation of the existing processes [6,7], or adopt an
alternative strategy through the detection of different sized DNA
fragments using direct PCR and melt curve analyses [8,9].
Streamlining the laboratory processes is certainly desirable but
will not necessarily address the issue that the number of samples,
together with variable success rates, often leads to a backlog of
items awaiting analyses [10]. When the biological stain is easily
identiﬁable and rich in DNA (e.g. visible blood, saliva or semen
stain) submitted items are likely to yield informative STR results
[11,12]. However, in the absence of any prior information,
submitting items for DNA analyses becomes increasingly subjec-
tive and can result in an increased number of items being
submitted which do not return a result [13,14]. The submission of
items of this kind requires a degree of training and personal
experience, which varies between individuals and enforcement
agencies [11,12].article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-
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submitted evidence item occurs after sample examination, DNA
extraction and quantiﬁcation. The hands-on time required to go
through this process and generate an STR proﬁle can take as little
as 8–10 h, although in many instances the enforcement authority
will not receive results for several weeks or months, with costs
being incurred even if samples fail. Moving to an objective
submission policy would enable a forensic laboratory to select
speciﬁc samples for analysis, saving time and resources whilst
improving the success rates of submitted items and reducing the
number of items awaiting analyses. A similar model is already
employed with presumptive biological tests [15–17] and recent
work has described the utility of screening for DNA using melt
curve analyses [8].
Here we present the developmental validation of the Para-
DNA1 Screening System developed by LGC Forensics, an instru-
ment for use outside the laboratory designed for the detection of
human DNA on forensic evidence items. Validation experiments
were designed to address guidelines laid out by the Scientiﬁc
Working Group on DNA Analysis Methods (SWGDAM) [18].
Experiments to characterise the performance of the ParaDNA
Screening System were performed at LGC Forensics, with the
inter-laboratory reproducibility trials performed in collaboration
with Florida International University (FIU) and the University of
Central Florida (UCF). The data presented here indicates the utility
of performing presumptive DNA testing by trained DNA analysts
in a laboratory or by non-specialist enforcement ofﬁcers prior to
item submission.
2. Materials, methods and techniques
The validation described below characterises keys aspects of
the ParaDNA Screening System. The data can be used to determine
critical factors in the screening process and determine the
limitations of the technology.
2.1. ParaDNA Screening System
The ParaDNA Screening System comprises the following:
The ParaDNA Screening Unit (Life Technologies1: 4484402) is
the instrument used to run the ParaDNA Screening Test (Electronic
Supplementary Material Fig. 1a). The instrument contains a
thermal cycler and a ﬂuorescence detection system and is designed
to function in a laboratory, scientiﬁc support unit or ofﬁce. The unit
can process up to four samples independently at the same time.
The ParaDNA Sample Collector (Life Technologies1: 4484203)
is a disposable plastic device used in a similar manner as a
traditional cotton swab (Electronic Supplementary Material
Fig. 1b). Collection of cellular material occurs through adsorption
onto the plastic head of the device and can be recovered from both
evidential swabs (termed indirect sampling) or directly from an
evidence item (termed direct sampling). The device is operated by
pushing the collar, forcing four sampling tips into a closed position
ready for collection (Electronic Supplementary Material Fig. 1c).
After sampling, this process is reversed separating the tips before
the sample collector is inserted into the 4-well PCR plate,
introducing the DNA template while simultaneously sealing the
PCR wells.
The ParaDNA Screening Test (Life Technologies1: 4484202)
contains four independent PCR [19] reactions pre-loaded into the
custom designed 4-well PCR plate (Electronic Supplementary
Material Fig. 1d). The assay uses HyBeaconTM technology [9,20] to
amplify and detect 2 STRs and the Amelogenin gender marker. The
TH01 locus (ampliﬁed fragment size 143-187 bp, alleles detected
5-9.3 + ), D16S539 locus (ampliﬁed fragment size 131-183 bp,
alleles detected alleles 8-15 + ) and the gender marker Amelogenin(ampliﬁed fragments size 188-194 bp, alleles detected X, Y) are
separated into each of the four wells.
The ParaDNA Software controls the instrument, analyzes the
data and displays the screening result. The software detects
changes in ﬂuorescence (DRFU) as a HyBeacon probe melts away
from its ampliﬁed allele at a speciﬁc melting temperature (TM)
between 20 8C and 70 8C (Electronic Supplementary Material
Fig. 2a). The temperature at which this ﬂuorescence change occurs
varies with the length of the ampliﬁed allele. This temperature
separation enables the software to attribute a proportion of the
overall ﬂuorescence change to each possible allele. System
variability causes small ﬂuorescence changes even when an allele
has not been ampliﬁed. This system noise is determined by
considering data from a large number of samples (Electronic
Supplementary Material Fig. 2b). Some of these are known to
contain the allele of interest and others do not. The noise is then
rejected with a simple threshold. The software converts this data
into an easily interpretable colour-coded ‘DNA Detection’ result as
follows:
 Red–No DNA Detected. Fluorescence change consistent with
negative control data.
 Green–DNA detected. Fluorescence change consistent with
positive control data.
In addition to the red/green DNA Detection result, a percentage
score provides an indication of the amount of DNA loaded into the
reaction, allowing the user to select which item to preferentially
submit for laboratory analysis if multiple items from the same
evidence item are obtained. The software also provides gender
information (Electronic Supplementary Material Fig. 3).
2.2. Validation Studies
The sensitivity and precision of the DNA Detection and
Gender Identiﬁcation functions were assessed by analysing ﬁve
puriﬁed extracted genomic DNA samples over a range of DNA
input amounts (4 ng, 3 ng, 1 ng, 500 pg, 250 pg, 62.5 pg). These
inputs represent the total amount of template added across the
four assay tubes with each tube amplifying one quarter of the
stated amount. Six replicates were analysed at each DNA input
amount and an additional 30 No Template Control (NTC)
samples were also analysed. The DNA was added to each
reaction plate prior to dispensing the required volume of
reaction mix. All samples used were obtained from the Health
Protection Agency Typed Collection and quantiﬁed (Promega
Plexor1 HY: DC1001) and standardised to a concentration of
1 ng/ml before dilution.
The accuracy and sensitivity of the ParaDNA System was
assessed by performing a mock case sample study. Samples tested
were 10 ml blood on glass (n = 20), 10 ml blood on concrete
(n = 17), 50 ml saliva on cotton (n = 22), tools handled for
5 minutes (n = 25), latex gloves worn for 10-20 minutes (n = 30)
and ﬁngerprints on glass after donors rubbed their ﬁngertips
together for 1 minute (n = 28). Samples were chosen to represent a
range of template levels and were collected from LGC Forensics’
staff members with the donor’s consent. All mock samples
underwent ‘indirect sampling’ with evidence items being wet
and dry swabbed using rayon swabs (Fisher Scientiﬁc: DIS-255-
065 N) following an LGC Standard Operating Procedure (SOP)
before sub-sampling from the wet swab using the ParaDNA Sample
Collector. Collection from the swab, rather than directly from the
item served to standardise the test substrate and enabled the user
to sub-sample within 60 seconds. In the process of sampling, the
swab head ﬁbres were teased apart increasing the surface area of
the swab head and thereby encouraging more cellular material to
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sampling were wet and dry swabbed only to assess what impact
the ParaDNA collection process had on the level of available
template for subsequent laboratory DNA analysis. This group
comprised of blood on glass (n = 19), blood on concrete (n = 18),
saliva on cotton (n = 23), touched tools (n = 23), latex gloves
(n = 42) and ﬁngerprint on glass (n = 42). All swabs were sent to the
LGC Scene of Crime DNA operations unit for extraction (Qiagen
QIAsymphony DNA Investigator chemistry: 952034) and quantiﬁ-
cation (Promega Plexor1 HY: DC1001).
Items sampled with the ParaDNA Sample Collector that
subsequently yielded DNA with a measured concentration of less
than 50 pg/ml also underwent subsequent STR ampliﬁcation
(Applied BioSystems/Life Technologies AmpFlSTR1 SGM Plus1
system: 4307133) and separation by CE (Applied BioSystems/Life
Technologies, ABI3100xl). Samples that yielded more than 50 pg/
ml of DNA were assumed suitable to provide a full SGM Plus proﬁle.
Substrate background controls (leather, denim, polypropylene,
polycarbonate, polystyrene, cement, aluminium) were sterilised
by dual cycle ethylene oxide treatment [21] and included in the
trial to assess the impact of substrate interference and background
noise on the ParaDNA result.
The inter-laboratory reproducibility of the ParaDNA sampling
process was assessed by comparing data generated by staff at
Florida International University (FIU) and the University of Central
Florida (UCF) with a control user from LGC Forensics. Ten replicate
swabs (Fisher Scientiﬁc: 23-400-114) spiked with 50 ml saliva
solution were tested by each operator at a range of dilutions (Neat,
1 in 10, 1 in 100, blank).
The recovery of cellular material using the ParaDNA Sample
Collector from different swab types was assessed by spiking three
commonly used swab types (TSC Ltd Cotton Swab: DIS-295-010 K,
Sterilin Flocked Swabs: DIS-275-070G and Sterilin Rayon Swabs:
DIS-255-065 N) with 50 ml of a homogeneous saliva solution
across three dilutions. Eight replicates of each swab at each saliva
dilution (Neat, 1 in 16, 1 in 100) were sub-sampled using the
standard procedures described above.
DNA samples from crime scenes often contain co-puriﬁed
impurities which inhibit PCR [13]. The direct PCR approach used by
the ParaDNA Screening unit means there is no puriﬁcation process
and the carryover of inhibitors into the PCR mix may be more likely
than in a traditional STR analysis system. The tolerance to
inhibition of the ParaDNA Screening Test was assessed by spikingFig. 1. Sensitivity plot showing DNA Detection Score decreasing as a function of input amo
of the mean (SEM). Cell line reference numbers are provided.controlled amounts of common PCR inhibitors into the assay
containing 2 ng (assay total) of a puriﬁed DNA template (Health
Protection Agency Typed Collection, Cell Line: WT100BIS). Final
concentrations of humic acid at 2.5, 5, 10 and 25 ng/ml (Sigma:
53680), tannic acid at 12.5, 25, 50 and 125 ng/ml (Sigma: 403040)
and hemin at 12.5, 25 and 50 mmol/L (Sigma: 51280) were all
tested.
The utility of the ParaDNA Screening Test for detecting the Y
target in mixed male/female samples was assessed using puriﬁed
genomic DNA (Health Protection Agency Typed Collection, Cell
Lines: SG00063 mixed with EK-TOK) at a number of different ratios
(Female:Male 1:0, 90:10, 70:30, 50:50, 30:70, 10:90, 0:1). Three
replicates at each ratio were tested at 4 ng and 1 ng total input for
puriﬁed DNA mixtures.
The speciﬁcity of the ParaDNA assay for human DNA was
addressed by introducing 1 ng of puriﬁed DNA from 12 common
test species (chimpanzee, dog, pig, rabbit, cat, horse, sheep, rat,
cow, C. albicans, S. aureus and E. coli) in triplicate into ParaDNA
Screening Test PCR mixes (DNA available from HPA Culture
Collections).
2.3. Ampliﬁcation and Data Analyses
Ampliﬁcation was performed on the ParaDNA Screening Unit
using a developmental batch of the ParaDNA Screening Test and
demonstrates what is achievable in a laboratory setting. All data
was analysed using the ParaDNA software v 1.0.1.0 except the
speciﬁcity experiments which were performed on a BioRad CFX96
Real-Time PCR Detection System. Data was checked for normality
(Anderson Darling Test) and for variance (Levene’s Test) before
statistical analyses was performed. A Mann-Whitney U test was
used to identify differences in the Plexor-HY quantiﬁcation results
between mock items that had undergone ParaDNA sampling and
items that had not. A t-Test was used to identify differences
between operators and an Anova to test swab types. All statistical
tests were performed at the p  0.05 level.
3. Results and Discussion
The ParaDNA System provides a DNA Detection Score (%) based
on the total change in ﬂuorescence across all tubes for the
ampliﬁed alleles. The sample mean DNA Detection Scores are
shown for a range of DNA input amounts in Fig. 1. DNA wasunt. Precision of the measurements at each level are indicated by the standard error
Fig. 2. DNA Detection score (%) (rolling mean every 5 samples) vs Plexor HY autosomal quantiﬁcation (ng/ml). Plexor quantiﬁcation values capped at 0.5 ng/ul.
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measurement is increased at high levels of input DNA (as shown
by the reduced SEM at 1, 3 and 4 ng DNA). Precision was reduced at
low DNA input levels, an observation consistent with many
detection platforms. The ParaDNA Screening Test only requires
DNA ampliﬁcation in a single independent tube to provide a green
DNA Detection Score. Conversely, ampliﬁcation product must be
absent in all four tubes for a red ‘No DNA Detected’ result to be
provided. The probability of observing a red ‘No DNA Detected’
result at each of the DNA levels tested was calculated by
multiplying the probability of observing a failed ampliﬁcation in
each tube (A, B, C, D). At the lowest level tested (62.5 pg) the
probability of obtaining such a result by reaction tube is 33%, 42%,
37% and 47%. This equates to a 2.4% chance of no ampliﬁcation
simultaneously in all four tubes, or a success rate of 97.6% when
62.5 pg is added to the assay. The observed outcomes in the 30
analyses with 62.5 pg input DNA were that ampliﬁcation was seen
in at least one of the four tubes 28/30 = 93%, close to the calculated
probability. The highest amount of DNA added to the assay wasFig. 3. Box plot showing DNA quantities recovered from mock evidence items that have b
DNA extraction and quantiﬁcation. Whiskers represent max and min data points.4 ng and this high level did not negatively affect the observed
result (Fig. 1). There were two instances (out of 30) in which
negative control replicates indicated ampliﬁcation due to low level
contamination.
The accuracy of the ParaDNA Screening DNA Detection Score
was assessed by comparison to the DNA concentration obtained
after Plexor-HY quantiﬁcation (Fig. 2). The plots illustrate strong
correlation between the ParaDNA Screening DNA Detection Score
and Plexor DNA quantiﬁcation. The impact of using the ParaDNA
Sample Collector to recover cellular material from evidence items
and its impact on the downstream process was further assessed by
comparing the amount of DNA extracted from mocked-up items
that had been sampled using the ParaDNA Sample Collector with
samples that did not undergo any ParaDNA Screening (Fig. 3). The
data show no signiﬁcant difference (Mann-Whitney U Test p =
> 0.05) in quantiﬁcation result between samples that had
undergone ParaDNA Screening and those that had not. This
suggests that the ParaDNA Sample Collector recovers a small
proportion of the available DNA and any impact that the ParaDNAeen unsampled vs samples that have undergone ParaDNA indirect sampling prior to
Table 1
SGMPlus proﬁling success of mock evidence items used to measure the accuracy of the ParaDNA Screening System.
Category Blood n Saliva n Touch n Blanks n Total Data Set n
True +ves 100.00% 37 100.00% 22 33.73% 28 0.00% 0 44.62% 87
True -ves 0.00% 0 0.00% 0 42.17% 35 98.11% 52 44.62% 87
False +ves 0.00% 0 0.00% 0 7.23% 6 1.89% 1 3.59% 7
False -ves 0.00% 0 0.00% 0 16.87% 14 0.00% 0 7.18% 14
Total 37 22 83 53 195
14 volunteers provided the sample data set. Successful proﬁle deﬁned as returning 14 or more alleles. True Positives (ParaDNA DNA Detection Score was green and the STR
proﬁle yielded 14 alleles), True Negatives (ParaDNA DNA Detection Score was red and the STR proﬁle yielded <14 alleles), False Positives (ParaDNA DNA Detection Score was
green and the STR proﬁle yielded <14 alleles), or False Negatives (ParaDNA DNA Detection Score was red and the STR proﬁle yielded 14 alleles).
Table 2
Gender call sensitivity at various DNA input levels.
1 ng n 750 pg n 250 pg n 125 pg n 62.5 pg n 15.6 pg n
Gender Provided 100% 30 100% 27 90% 27 81% 22 90% 26 47% 14
Gender Not Provided 0% 0 0% 0 10% 3 19% 5 10% 3 53% 16
* Data set of 67 Female, 106 Male. DNA concentration represents the total amount of DNA in the amelogenin reaction. Samples used in the gender sensitivity study are the
same as those used in the DNA Detection Sensitivity Study and are available from HPA Culture collections.
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masked by the overall variability in yield caused by variation in
sample preparation, swabbing efﬁciency and DNA recovery.
STR typing was performed on all samples that gave a
quantiﬁcation result of  50 pg/ml. Using the ampliﬁcation of 14
or more alleles as a benchmark indicator that the SGMPlus proﬁle
was ‘usable’, samples were categorised as either True Positives,
True Negatives, False Positives, or False Negatives (Table 1).
Samples that yielded more than 50 pg/ml of DNA were assumed
suitable to provide a full SGM Plus proﬁle. The data displayed in
Table 1 indicate that blood and saliva consistently gave accurate
results, while the touch DNA samples contained some instances
where the ParaDNA and laboratory testing gave differing results.
The STR proﬁling success rate of samples is known to vary [12],
with touch DNA samples being amongst the poorest sample type
submitted for STR proﬁling [14]. In this study the percentage of
touch DNA samples (latex gloves, tools, ﬁngerprints) that gave an
STR proﬁle of  14 alleles was 51% (42/83 samples). If the ParaDNA
System had been used to identify which samples to preferentially
submit for STR proﬁling the success rate of the submitted samples
would have been 82% (28/34 samples). While this represents a
reduction in the number of successful proﬁles obtained from this
group of 83 samples (42 with no ParaDNA vs 28 with ParaDNA) it
also represents a potential cost saving from the samples that were
not submitted. This cost saving will allow a forensic service
provider to screen and submit additional evidence items from
other groups and thereby improve their overall success rate.
It is not possible to assess whether the false negative rate
presented in Table 1 obtained after using the ParaDNA Screening
System is higher or lower than that achieved based on a traditional
submissions approach as the identiﬁcation of false negatives is
only possible if there is a method to identify the false negatives. In
practice, any item not currently submitted for STR proﬁling which
would have given a full proﬁle if submitted could be treated as
equivalent to a false negative. Using the binary classiﬁcation test toTable 3
Gender call accuracy across mock evidence items.
Blood on Concrete Blood on Glass Finger Prints 
Gender ID n Gender ID n Gender ID 
Correct 100% 17 95% 19 7% 
Incorrect 0% 0 0% 0 0% 
Unknown 0% 0 5% 1 93% 
Total 100% 17 100% 20 100% 
* Data set of 63 Female, 80 Maledescribe the proportion of true positives (sensitivity) and true
negatives (speciﬁcity) [22] across all sample types (blood, saliva,
and touch DNA) the system had a sensitivity of 86% and a
speciﬁcity of 93%. The data presented above suggest that the
ParaDNA System is capable of detection of DNA at low levels.
The sensitivity and accuracy of the gender identiﬁcation call in
the ParaDNA assay are dependent on results from a single tube
while the DNA Detection Score is summed from all four tubes.
Therefore the gender result is somewhat independent from the
sensitivity and accuracy of DNA Detection. The results obtained
using puriﬁed DNA are provided in Table 2. The data indicate a
gender result is obtained in > 80% samples at DNA levels at or
above 62.5 pg, although some sensitivity differences between male
and female samples were observed. Typically gender detection
sensitivity in males is greater due to the fact that when a Y target is
ampliﬁed the software automatically calls a male. The opposite is
not true for female samples. Given the presence of the X target in
male samples together with the possibility of allelic dropout
means that to accurately identify a female the X target melt curve
had to be sufﬁciently large so as to be conﬁdent it is a genuine
female XX and not a male X with Y dropout. The accuracy of the
gender assignment was also measured from the 143 mock
evidence items processed in this study; there were no examples
of inaccurate calls (Table 3).
The inter-laboratory reproducibility of the ParaDNA system was
assessed by operators with different experience levels and based in
different laboratories sampling from spiked swabs (Fig. 4). There
was no signiﬁcant difference in the DNA Detection Scores
generated between users (t-test p = > 0.05) indicating that each
user recovered the same amount of DNA within each spike
treatment. There was no signiﬁcant difference in the variance of
the DNA Detection Scores, demonstrating that each user showed
equivalent levels of precision when using the ParaDNA Sample
Collector. Applications that use direct PCR often suffer from
stochastic sampling effects [1] and it is likely that this accounts forLatex Gloves Saliva on Cotton Tools
n Gender ID n Gender ID n Gender ID n
2 13% 4 64% 14 28% 7
0 0% 0 0% 0 0% 0
26 87% 27 36% 8 72% 18
28 100% 31 100% 22 100% 25
Fig. 4. Box plot showing inter-laboratory reproducibility of DNA Detection Scores from mock evidence items sampled by different users in different laboratories. Whiskers
represent max and min data points.
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the DNA Detection Scores generated between the spike treatments
(t-test p = < 0.05) indicating that the assay was able to identify
which swabs were spiked with high, medium and low levels of
template material. Overall, the data presented here suggest that
the ParaDNA system can be used by different operators and
different laboratories regardless of experience. The data also shows
that the system can be used to identify which evidence items hold
more template material, information which can be used to triage
evidence items.
Given the number of swab types available for forensic
practitioners to use it is necessary to assess their performance.
Some studies have shown that Flocked swabs are more effective at
collecting cellular material while other studies observed no
difference between swab types [23–26]. The study described hereFig. 5. Inhibitor tolerance of ParaDNA Screening Test. Three commdid not look at the collection efﬁciency of these swab types but
rather the transfer efﬁciency from the swabs to the ParaDNA
Sample Collector (Electronic Supplementary Material Fig. 4). There
was a signiﬁcant difference between swabs at the 1 in 16 dilution
level (Anova p = < 0.05) but no signiﬁcant differences were
observed at the neat and 1 in 100 levels. This suggests that each of
the swabs tested can be used in conjunction with the ParaDNA
System and while some variation in the mean DNA Detection Score
was observed, there were no appreciable differences between the
swabs trialled. It is recommended that further validation be
performed if swabs other than those trialled in this study are used
with the ParaDNA Sample Collector.
The impact of common inhibitors on the DNA Detection Score
was assessed by adding known amounts of inhibitor into the
reaction mixes (Fig. 5). The data demonstrated that positive DNAon inhibitors were tested across a variety of concentrations.
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ml Tannic acid, 10 ng/ml Humic acid and 25 mmol/L Hemin.
However, DNA Detection Scores decreased as the amount of
inhibitor increased. Overcoming inhibition is a problem for all PCR
based assays [13], especially those employing direct PCR which do
not utilise a sample clean-up step [1]. The level of tolerance to
these model inhibitors demonstrated by the ParaDNA Screening
Test in this study is lower than that documented for some
commercial ‘next generation’ STR kits [1,27], although further
work on the analyses of contaminated mock casework items is
required.
As the ParaDNA System ampliﬁes both X and Y targets there is
some scope to use the ParaDNA Screening Test to identify the
presence of male contributions in a female sample by the detection
of the Y allele. At 4 ng input the Y target was detected at all ratios
tested except the single source female. At 1 ng input the Y target
was detected at all ratios tested except the single source female
and 90:10 Female:Male ratio. The data suggests that there is some
potential to use the ParaDNA Screening System to triage possible
mixed male/female samples to identify the presence of male
contributions. This functionality is of potential use in cases
investigating sexual assault where the detection of male samples
may provide evidential strength to a victim’s testimony. The work
presented here is considered a preliminary study and further work
characterising the ParaDNA Screening System for this type of
application is currently under review for publication [28].
Summary
Here we have described the validation of the ParaDNA
Screening System, a presumptive test for the presence of DNA
which allows users to preferentially select items to submit for STR
analyses and thereby increase proﬁling success rates, reduce
backlogs and make cost savings.
The data presented here demonstrate that the ParaDNA
Screening system detected human DNA from puriﬁed DNA
samples and swabbed, mocked-up evidence items with similar
sensitivity to that demonstrated by commonly used STR proﬁling
products. In addition, the ease of use of the ParaDNA Screening
system by specialist and non-specialist users in several labs was
demonstrated. The production of positive DNA scores from a
variety of substrate and swab types and in the presence of
inhibitors was observed.
The use of the ParaDNA System is not designed to replace
existing technology or processes, but acts to improve the
submissions policy of non-laboratory based groups such as law
enforcement agencies and to supplement the arsenal of forensic
technologies available to all practitioners. Laboratories intending
to use the ParaDNA Screening System are recommended to
perform their own operational/internal validation studies prior to
implementation.
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